Blue Earth Diagnostics
UK - OxfordDiagnostics
Focus: Blue Earth Diagnostics is a UK-based molecular imaging company founded in 2014, specializing in positron emission tomography (PET) diagnostics across oncology, neurology, and cardiovascular indications. The company operates 101 active job openings and maintains a focused portfolio of FDA-approved imaging agents.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Blue Earth Diagnostics
AI assessmentNot HiringNo open roles listed right now. Follow Blue Earth Diagnostics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Peak15.9yr
Core revenue driver with 17-year patent exclusivity; positioned as flagship diagnostic for prostate cancer localization.
Help build intelligence for Blue Earth Diagnostics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.